Retracted: Metallothionein I1II expression and their role in experimental autoimmune encephalomyelitis (Glia, (2000), 32, 2, (247-263), 10.1002/1098-1136(200012)32:3<247::AID-GLIA50>3.0.CO;2-T);Metallothionein I+II expression and their role in experimental autoimmune encephalomyelitis

GLIA

Volumn 32, Issue 3, 2000, Pages 247-263

  Penkowa, Milena ^a   Hidalgo, Juan ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

EAE MS; Free radicals; Immunotherapy; Neuroimmunology

Indexed keywords

EID: 0033662509     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.23257     Document Type: Erratum

References (60)

1. The functional significance of brain metallothioneins
2. Astrocytic functions and physiological reactions to injury: The potential to induce and/or exacerbate neuronal dysfunction - A forum position paper
3. Metallothionein (MT) isoforms in the central nervous system (CNS): Regional and cell-specific distribution and potential functions as an antioxidant
4. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis
5. Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis
6. The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis
7. Metallothionein protects DNA from copper-induced but not iron-induced cleavage in vitro
8. Metallothionein (MT)-III: Generation of polyclonal antibodies, comparison with MT-I+II in the freeze lesioned rat brain and in a bioassay with astrocytes, and analysis of Alzheimer's disease brains
9. Enhanced seizures and hippocampal neurodegeneration after kainic acid induced seizures in metallothionein-I+II deficient mice
10. An evaluation of the role of mitochondria in neurodegenerative diseases: Mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration
11. Tumor necrosis factor-alpha-dependent production of reactive nitrogen intermediates mediates IFN-gamma plus IL-2-induced murine macrophage tumoricidal activity
12. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice
13. Local delivery of TNF by retrovirus-transduced T lymphecytes exacerbates experimental autoimmune encephalomyelitis
14. Transgenic and knockout analyses of the role of TNF in immune regulation and disease pathogenesis
15. Molecular profile of reactive astrocytes - Implications for their role in neurologic disease
16. Inflammation in EAE: Role of chemokine/cytokine expression by resident and infiltrating cells
17. Development of a competitive double antibody radioimmunoassay for rat metallothionein
18. Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulation
19. Selective degeneration of oligodendrocytes mediated by oxygen radical species
20. Regulation of brain metallothioneins
21. Oligodendroglial cell death induced by oxygen radicals and its protection by catalase
22. Effect of reactive oxygen species on myelin membrane proteins
23. Effect of non-toxic mercury, zinc or cadmium pretreatment on the capacity of human monocytes to undergo lipopolysaccharide-induced activation
24. Enhanced sensitivity to oxidative stress in cultured embryonic cells from transgenic mice deficient in metallothionein I and II genes
25. The protein thiol metallothionein as an antioxidant and protectant against antineoplastic drugs
26. Metallothioneins and cell death by anticancer drugs
27. Antisense downregulation of metallothionein in a human monocytic cell line alters adherence, invasion, and the respiratory burst
28. Activation of human monocytes with lipopolysaccharide induces metallothionein expression and is diminished by zinc
29. Myelin basic protein content of aggregating rat brain cell cultures treated with cytokines and/or demyelinating antibody: Effects of macrophage enrichment
30. Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperaeute experimental autoimmune encephalomyelitis: Enhancement by the soluble products of encephalitogenic T cells
31. Microglial and astroglial reactions to inflammatory lesions of experimental autoimmune encephalomyelitis in the rat central nervous system
32. Interleukin-6 functions in autoimmune encephalomyelitis: A study in gene-targeted mice
33. Effect of nitric oxide synthesis inhibition on mouse liver and brain metallothionein expression
34. IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein
35. IL-6 plays a crucial role in the induction phase of myelin oligodendrocyte glucoprotein 35-55 induced experimental autoimmune encephalomyelitis
36. IL-6 deficiency leads to reduced metallothionein I+II expression and increased oxidative stress in the brain stem after 6-aminonicotinamide treatment
37. Increased astrocytic expression of metallothioneins I+II in brain stem of adult rats treated with 6-aminonicotinamide
38. CNS wound healing is severely depressed in metallothionein-I and II-deficient mice
39. Strongly compromised inflammatory response to brain injury in interleukin-6 deficient mice
40. Impaired inflammatory response to glial cell death in geneticly metallothionein-I+II deficient mice
41. Prolonged inflammatory response to traumatic brain injury in metallothionein-I+II deficient mice
42. Overexpression of metallothionein decreases sensitivity of pulmonary endothelial cells to oxidant injury
43. Spinal cord neuropathology in rat experimental autoimmune encephalomyelitis: Modulation by oral administration of myelin basic protein
44. Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha
45. Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide
46. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines
47. Reactive oxygen species are involved in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats
48. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: Roles of IL-6 in the activation and differentiation of autoreactive T cells
49. The role of nitric oxide in the pathogenesis of multiple sclerosis
50. Metallothionein protects against the cytotoxic and DNA-damaging effects of nitric oxide
51. Reactive oxygen species in experimental allergic encephalomyelitis
52. Zinc and immune function: The biological basis of altered resistance to infection
53. Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease
54. Yeast and mammalian metallothioneins functionally substitute for yeast copper-zinc superoxide dismutase
55. Increased severity of experimental autoimmune encephalomyelitis, chronic macrophage/microglial reactivity, and demyelination in transgenic mice producing tumor necrosis factor-alpha in the central nervous system
56. Possible role for metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals
57. Neurotrophic activity in cytokine-activated astrocytes
58. Appearance of inducible nitric oxide synthase in the rat central nervous system after rabies virus infection and during experimental allergic encephalomyelitis but not after peripheral administration of endotoxin
59. Evidence for a protective role of metallothionein-1 in focal cerebral ischemia
60. Activated non-neural specific T cells open the blood-brain barrier to circulating antibodies